Laura Holman to Uterine Cervical Neoplasms
This is a "connection" page, showing publications Laura Holman has written about Uterine Cervical Neoplasms.
Connection Strength
3.544
-
Incorporation of whole pelvic radiation into treatment of stage IVB cervical cancer: A novel treatment strategy. Gynecol Oncol. 2020 01; 156(1):100-106.
Score: 0.543
-
Improving cancer care for American Indians with cervical cancer in the Indian Health Service (IHS) system - Navigation may not be enough. Gynecol Oncol. 2018 04; 149(1):89-92.
Score: 0.484
-
Status epilepticus associated with platinum chemotherapy in a patient with cervical cancer: a case report. BMC Cancer. 2015 Oct 17; 15:728.
Score: 0.408
-
Sentinel lymph node evaluation in women with cervical cancer. J Minim Invasive Gynecol. 2014 Jul-Aug; 21(4):540-5.
Score: 0.361
-
Incorporation of triapine (T) to cisplatin chemoradiation (CRT) for locally advanced cervical and vaginal cancer: Results from NRG-GY006, a phase III randomized trial. Gynecol Oncol. 2025 Apr; 195:122-133.
Score: 0.196
-
Evaluation of physical function and quality of life before and after nonradical surgical therapy for stage IA1 and IA2-IB1 cervical cancer (GOG-0278). Gynecol Oncol. 2025 Apr; 195:50-58.
Score: 0.196
-
Evaluation of efficacy and fertility after nonradical surgical therapy (extra fascial hysterectomy or cone biopsy, with pelvic lymphadenectomy) for stage IA1, IA2, and IB1 cervical cancer (GOG-0278). Gynecol Oncol. 2025 Apr; 195:59-65.
Score: 0.195
-
Update on safety and feasibility of the combination of pembrolizumab and pelvic chemoradiation in locally advanced cervical cancer. Cancer. 2025 Feb 15; 131(4):e35757.
Score: 0.195
-
Neoadjuvant or concurrent atezolizumab with chemoradiation for locally advanced cervical cancer: a randomized phase I trial. Nat Commun. 2025 Jan 09; 16(1):553.
Score: 0.193
-
A phase II trial of bevacizumab and rucaparib in recurrent carcinoma of the cervix or endometrium. Gynecol Oncol. 2022 07; 166(1):44-49.
Score: 0.160
-
Beyond Sedlis-A novel histology-specific nomogram for predicting cervical cancer recurrence risk: An NRG/GOG ancillary analysis. Gynecol Oncol. 2021 09; 162(3):532-538.
Score: 0.151
-
Pathologic and clinical tumor size discordance in early-stage cervical cancer: Does it matter? Gynecol Oncol. 2020 11; 159(2):354-358.
Score: 0.143
-
Recurrence Rates in Patients With Cervical Cancer Treated With Abdominal Versus Minimally Invasive Radical Hysterectomy: A Multi-Institutional Retrospective Review Study. J Clin Oncol. 2020 04 01; 38(10):1030-1040.
Score: 0.137
-
Adenocarcinoma of the cervix involving the fallopian tube mucosa: report of a case. Diagn Pathol. 2016 Aug 17; 11(1):77.
Score: 0.108
-
Update on sentinel lymph node evaluation in gynecologic malignancies. Curr Opin Obstet Gynecol. 2011 Feb; 23(1):8-12.
Score: 0.074